IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation.

Source:http://linkedlifedata.com/resource/pubmed/id/19167680

Download in:

View as

General Info

PMID
19167680